Sabra Enterprise Value Over E B I T D A from 2010 to 2024
| SBRA Stock | USD 18.91 0.07 0.37% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 18.29524609 | Current Value 29.83 | Quarterly Volatility 25.46550128 |
Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 116.9 M, Interest Expense of 83.2 M or Selling General Administrative of 29.5 M, as well as many indicators such as Price To Sales Ratio of 10.03, Dividend Yield of 0.0653 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
Sabra | Enterprise Value Over E B I T D A |
Latest Sabra Healthcare's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Sabra Healthcare REIT over the last few years. It is Sabra Healthcare's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sabra Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Sabra Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 27.30 | |
| Geometric Mean | 20.89 | |
| Coefficient Of Variation | 93.27 | |
| Mean Deviation | 16.96 | |
| Median | 17.09 | |
| Standard Deviation | 25.47 | |
| Sample Variance | 648.49 | |
| Range | 97.6056 | |
| R-Value | (0.50) | |
| Mean Square Error | 526.01 | |
| R-Squared | 0.25 | |
| Significance | 0.06 | |
| Slope | (2.83) | |
| Total Sum of Squares | 9,079 |
Sabra Enterprise Value Over E B I T D A History
About Sabra Healthcare Financial Statements
Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 18.30 | 29.83 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out the analysis of Sabra Healthcare Correlation against competitors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.111 | Dividend Share 1.2 | Earnings Share 0.41 | Revenue Per Share 2.943 | Quarterly Revenue Growth 0.107 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.